# ClinicalTrials.gov record NCT03965130

> PeptideScanner retained ClinicalTrials.gov record NCT03965130 at 2026-07-30T18:38:25.510Z. Its registry update date was 2024-11-26, and PeptideScanner's reviewed identity mapping was glucagon.

- Evidence object: `story:clinicaltrials-gov-nct03965130-glucagon:v1`
- Evidence domain: Clinical trials
- Date in source: 2024-11-26
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct03965130-glucagon/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03965130-glucagon-v1.json
- Content SHA-256: `6f78842fb66cea5ee98bb51f2838fdad7f090c3b42a4b7243b08254b76bff112`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT03965130 ([`ctg-observation-nct03965130-2024-11-26-8f35b692607d`](#source-ctg-observation-nct03965130-2024-11-26-8f35b692607d))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT03965130 at 2026-07-30T18:38:25.510Z. Its registry update date was 2024-11-26, and PeptideScanner's reviewed identity mapping was glucagon. ([`ctg-observation-nct03965130-2024-11-26-8f35b692607d`](#source-ctg-observation-nct03965130-2024-11-26-8f35b692607d))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT03965130 at 2026-07-30T18:38:25.510Z. Its registry update date was 2024-11-26, and PeptideScanner's reviewed identity mapping was glucagon. ([`ctg-observation-nct03965130-2024-11-26-8f35b692607d`](#source-ctg-observation-nct03965130-2024-11-26-8f35b692607d))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct03965130-2024-11-26-8f35b692607d`](#source-ctg-observation-nct03965130-2024-11-26-8f35b692607d))

## Sources

<a id="source-ctg-observation-nct03965130-2024-11-26-8f35b692607d"></a>
- **ClinicalTrials.gov record NCT03965130 · retained source version 2024-11-26:8f35b692607de14de3250b6386c909e6b01a56fd976c0fa313f9e4286f6ef7b7** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT03965130) (`ctg-observation-nct03965130-2024-11-26-8f35b692607d`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT03965130." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03965130-glucagon-v1.json SHA-256: 6f78842fb66cea5ee98bb51f2838fdad7f090c3b42a4b7243b08254b76bff112.